Global asset management firm The Carlyle Group has reportedly sold 46 million shares of Hong Kong-listed medical device manufacturer Microport Scientific for HKD8.40 (approximately US$1.07) per share, generating proceeds of HKD386 million (approximately US$49.4 million). Carlyle originally invested in the company in 2016 through Carlyle Asia Partners IV.